Bedell Frazier Investment Counseling, LLC Dexcom Inc Transaction History

Bedell Frazier Investment Counseling, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $169,960 - $245,340	2,000 New	2,000 $226,000
Q2 2022 Aug 03, 2022	SELL	$67.99 - $132.89 $33,995 - $66,445	-500 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $40,495 - $53,965	500 New	500 $214,000
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $39,000 - $52,250	-500 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $31,340 - $52,670	500 New	500 $203,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bedell Frazier Investment Counseling, LLC, based on Form 13F filings with the SEC.

Stay updated on Bedell Frazier Investment Counseling, LLC with notifications on news.